Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 3, 1997, Pages 408-414

  Lambiase, Alessandro ^a,b   Bracci Laudiero, Luisa ^a   Bonini, Sergio ^c   Bonini, Stefano ^b,c   Starace, Giuseppe ^a   D'Elios, Mario Milco ^d   De Carli, Marco ^d   Aloe, Luigi ^a  

^a CNR   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS FONDAZIONE BIETTI   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

CD4+ T cells; Lymphocyte; Nerve growth factor; TH2 clones; Tyrosine kinase receptor

Indexed keywords

NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PHYTOHEMAGGLUTININ; PROTEIN TYROSINE KINASE A;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CLONE; CELL CULTURE; CELL MEMBRANE; CULTURE MEDIUM; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

CD4-POSITIVE T-LYMPHOCYTES; CELL MEMBRANE; CELLS, CULTURED; CLONE CELLS; CULTURE MEDIA, CONDITIONED; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NERVE GROWTH FACTORS; PHYTOHEMAGGLUTININS; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; T-LYMPHOCYTE SUBSETS;

EID: 0031230429     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70256-2     Document Type: Article

References (47)

1. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987;237:1154-62.
2. Levi-Montalcini R, Aloe L, Alleva E. A role for nerve growth factor in nervous, endocrine and immune system. Progr Neuroendocrinimmunol 1990;1:1-10.
3. Stead RH, Bienenstock J, Stanisz AM. Neuropeptide regulation of mucosal immunity. Immunol Rev 1987;100:333-59.
4. Matsuda H, Coughlin MD, Bienenstock J, Denburg JA. Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc Natl Acad Sci USA 1988;85:6508-12.
5. Aloe L, Skaper SD, Leon A, Levi-Montalcini R. Nerve growth factor and autoimmune diseases. Autoimmunity 1994;19:141-50.
6. Aloe L, Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res 1977;133:358-66.
7. Boyle MDP, Lawman MJP, Gee AP, Young M. Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol 1985;134:564-8.
8. Horigome K, Pryor JC, Bullock ED, Johnson Jr EM. Mediator release from mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation. J Biol Chem 1993;268:14881-7.
9. Bischoff SC, Dahinden CA. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 1992;79:2662-99.
10. Thorpe LW, Perez-Polo JR. The influence of nerve growth factor on the in vitro proliferative response of rat spleen lymphocytes. J Neurosci Res 1987;18:134-9.
11. Otten U, Ehrhard P. Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci USA 1989;86:10059-63.
12. Thorpe LW, Werrbach-Perez K. Perez-Polo JR. Effects of nerve growth factor on the expression of interleukin-2 receptors on cultured human lymphocytes. Ann NY Acad Sci 1987;496:310-1.
13. Brodie C, Gelfand EW. Functional nerve growth factor receptors on human B lymphocytes: Interaction with IL-2. J Immunol 1992;148:3492-7.
14. Kimata H, Yoshida A, Ishioka C, Kusunoki T, Hosoi S, Mikawa H. Nerve growth factor specifically induces human IgG4 production. Eur J Immunol 1991;21:137-41.
15. Ebendal T. Function and evolution in the NGF family and its receptors. J Neurosci Res 1992;32:461-70.
16. Beutler B, van Huffel C. Unraveling function in the TNF ligand and receptor families. Science 1994;264:667-8.
17. Martin-Zanca D, Oskam R, Mitra G, Copeland T, Barbacid M. Molecular and biochemical characterization of the human trk protooncogene. Mol Cell Biol 1989;9:24-33.
18. Kaplan DR, Martin-Zanca D, Parada LF. Tyrosine phosphorylation and tyrosine kinase activity of the trk protooncogene product induced by NGF. Nature 1991;350:158-60.
19. Cordon-Carado C, Tapley P, Jing SQ, Nanduri V, O'Rourke E, Lamballe F, et al. The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3. Cell 1991;66:173-83.
20. Loeb DM, Maragos J, Martin-Zanca D, Chao MV, Parada LF, Greene LA. The trk proto-oncogene rescues NGF responsiveness in mutant NGF-nonresponsive PC12 cell lines. Cell 1991;66:961-6.
21. Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF, Chao MV. High-affinity NGF binding requires coexpression of the trk protooncogene and the low-affinity NGF receptor. Nature 1991;350:678-83.
22. Verdi JM, Birren SJ, Ibáñez CF, Persson H, Kaplan DR, Benedetti M, et al. p75LNGFR regulates Trk signal transduction and NGF-induced neuronal differentiation in MAH cells. Neuron 1994;12:733-45.
23. Ehrhard PB, Erb P, Graumann U, Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T cell clones. Proc Natl Acad Sci USA 1993;90:10984-8.
24. Muragaki Y, Timothy N, Height S, Hempstead BL, Chao MV, Trojanowski JQ, et al. Expression of trk receptors in the developing and adult human central and peripheral nervous system. J Comp Neurol 1995;356:387-97.
25. Morgan B, Thorpe LW, Marchetti D, Perez-Polo JR. Expression of nerve growth factor receptors by human peripheral blood mononuclear cells. J Neurosci Res 1989;23:41-5.
26. Ehrhard PB, Ganter U, Bauer J, Otten U. Expression of functional trk protooncogene in human monocytes. Proc Natl Acad Sci USA 1993;90:5423-7.
27. Bracci-Laudiero L, Aloe L, Levi-Montalcini R, Buttinelli C, Schilter D, Gillessen S, et al. Multiple sclerosis patients express increased levels of β-nerve growth factor in cerebrospinal fluid. Neurosci Lett 1992;147:9-12.
28. Aloe L, Tuveri MA, Carcassi U, Levi-Montalcini R. Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum 1992;35:351-5.
29. Lambiase A, Bonini S, Bonini S, Micera A, Magrini L, Bracci-Laudiero L, et al. Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis and relationship to conjunctival mast cells. Invest Ophthalmol Vis Sci 1995;36:2127-32.
30. Bonini SE, Lambiase A, Bonini ST, Angelucci F, Magrini L, Manni L, et al. Circulating nerve growth factor levels is enhanced in human allergic diseases: a neuroimmune marker for allergy? Proc Natl Acad Sci USA 1996;93:10955-60.
31. H2 subsets: doubt no more. Immunol Today 1991;12:256-7.
32. Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, Aloe L, et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 1994;91:3739-43.
33. Santambrogio L, Benedetti M, Chao MV, Muzaffar R, Kulig K, Gabellini N, et al. Nerve growth factor production by lymphocytes. J Immunol 1994;153:4488-95.
34. Del Prete GF, De Carli M, Mastromauro C, Biagiotti R, Macchia D, Falagiani P, et al. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991;88:346-50.
35. Aloe L, Alleva E, Bohm A, Levi-Montalcini R. Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream. Proc Natl Acad Sci USA 1986;83:6184-7.
36. Fitch FW, Lancki DW, Gajewski TF. T cell-mediated immune regulation. Help and suppression. In: Paul WE, editor. Fundamental immunology, 3rd ed. New York: Raven Press, 1993:733-45.
37. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989;46:111-47.
38. Lu B, Buck CR, Dreyfus CF, Black IB. Expression of NGF and NGF receptor mRNAs in the developing brain: evidence for local delivery and action of NGF. Exp Neurol 1989;104:191-9.
39. Lauterborn JC, Isackson PJ, Gall CM. Nerve growth factor mRNA-containing cells are distributed within regions of cholinergic neurons in the rat basal forebrain. J Comp Neurol 1991;306:439-46.
40. Kokaia Z, Bengzon J, Metsis M, Kokaia M, Persson H, Lindvall O. Coexpression of neurotrophins and their receptors in neurons of the central nervous system. Proc Natl Acad Sci USA 1993;90:6711-5.
41. Tuveri MA, Passiu G, Mathieu A, Aloe L. Nerve growth factor and mast cell distribution in the skin of patients with systemic sclerosis. Clin Exp Rheumatol 1993;11:319-22.
42. Aloe L, Moroni R, Mollinari C. Tirassa P. Schistosoma mansoni infection enhances the levels of NGF in the liver and hypothalamus. Neuroreport 1994;5:1030-32.
43. Bracci-Laudiero L, Aloe L, Levi-Montalcini R, Galeazzi M, Schilter D, Scully JL, et al. Increased levels of NGF in sera of systemic lupus erythematosus patients. Neuroreport 1993;4:563-5.
44. H2-Hke helper T cells in the conjunctiva of patients with vernal keratoconjunctivitis. J Immunol 1991;146:1169-74.
45. Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Ann Rev Immunol 1992;10:385-409.
46. Via CS, Tsokos GC, Bermas BL, Clerici M, Shearer GM. T cell-antigen presenting cell interactions in human systemic lupus erythematosus. Evidence for heterogeneous expression of multiple defects. J Immunol 1993;151:3914-22.
47. Takafuji S, Bischoff SC, De Weck AL, Dahinden CA. Opposing effects of tumor necrosis factor-α and nerve growth factor upon leukotriene C4 production by human eosinophils triggered with N-formyl-methionyl-leucyl-phenylalanine. Eur J Immunol 1992;22:969-74.